Related Experiment Video
Updated: Jul 26, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
LncRNA PCBP1-AS1 induces osteoporosis by sponging miR-126-5p/PAK2 axis
1Department of Rehabilitation Medicine, Chengdu First People's Hospital, Chengdu, China.
Aims:
Long non-coding RNAs (lncRNAs) act as crucial regulators in osteoporosis (OP). Nonetheless, the effects and potential molecular mechanism of lncRNA PCBP1 Antisense RNA 1 (PCBP1-AS1) on OP remain largely unclear. The aim of this study was to explore the role of lncRNA PCBP1-AS1 in the pathogenesis of OP.
Methods:
Using quantitative real-time polymerase chain reaction (qRT-PCR), osteogenesis-related genes (alkaline phosphatase (ALP), osteocalcin (OCN), osteopontin (OPN), and Runt-related transcription factor 2 (RUNX2)), PCBP1-AS1, microRNA (miR)-126-5p, group I Pak family member p21-activated kinase 2 (PAK2), and their relative expression levels were determined. Western blotting was used to examine the expression of PAK2 protein. Cell Counting Kit-8 (CCK-8) assay was used to measure cell proliferation. To examine the osteogenic differentiation, Alizarin red along with ALP staining was used. RNA immunoprecipitation assay and bioinformatics analysis, as well as a dual-luciferase reporter, were used to study the association between PCBP1-AS1, PAK2, and miR-126-5p.
Results:
The expression of PCBP1-AS1 was pre-eminent in OP tissues and decreased throughout the development of human bone marrow-derived mesenchymal stem cells (hBMSCs) into osteoblasts. PCBP1-AS1 knockdown and overexpression respectively promoted and suppressed hBMSC proliferation and osteogenic differentiation capacity. Mechanistically, PCBP1-AS1 sponged miR-126-5p and consequently targeted PAK2. Inhibiting miR-126-5p significantly counteracted the beneficial effects of PCBP1-AS1 or PAK2 knockdown on hBMSCs' ability to differentiate into osteoblasts.
Conclusion:
PCBP1-AS1 is responsible for the development of OP and promotes its progression by inducing PAK2 expression via competitively binding to miR-126-5p. PCBP1-AS1 may therefore be a new therapeutic target for OP patients.
Insights
Long non-coding RNA PCBP1-AS1 promotes osteoporosis by increasing PAK2 expression via sponging miR-126-5p. This lncRNA may serve as a novel therapeutic target for osteoporosis patients.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Long non-coding RNAs (lncRNAs) are key regulators in osteoporosis (OP) pathogenesis.
- The specific role and mechanism of lncRNA PCBP1 Antisense RNA 1 (PCBP1-AS1) in OP are not well understood.
Purpose of the Study:
- To investigate the function and molecular mechanism of lncRNA PCBP1-AS1 in the development of osteoporosis.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blotting to measure gene and protein expression.
- Cell proliferation and osteogenic differentiation assays (CCK-8, Alizarin red, ALP staining).
- RNA immunoprecipitation (RIP) and dual-luciferase reporter assays to elucidate molecular interactions.
Main Results:
- PCBP1-AS1 expression was elevated in OP tissues and decreased during osteoblast differentiation.
- PCBP1-AS1 knockdown enhanced human bone marrow-derived mesenchymal stem cell (hBMSC) proliferation and osteogenic differentiation.
- PCBP1-AS1 acts as a molecular sponge for miR-126-5p, leading to increased PAK2 expression.
Conclusions:
- PCBP1-AS1 promotes OP progression by upregulating PAK2 via the miR-126-5p/PAK2 axis.
- PCBP1-AS1 represents a potential therapeutic target for osteoporosis treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
PI3K/mTOR/AKT Signaling Pathway
The Nucleolus
TGF - β Signaling Pathway

